- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x K4O: ~{N}-[(2-fluorophenyl)methyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine(Non-covalent)
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.2: 2 residues within 4Å:- Chain A: Y.16, Q.18
Ligand excluded by PLIPEDO.3: 8 residues within 4Å:- Chain A: H.29, D.32, V.33, N.36
- Chain B: A.67, C.68
- Ligands: EDO.6, K4O.13
Ligand excluded by PLIPEDO.4: 2 residues within 4Å:- Chain A: D.21, S.22
Ligand excluded by PLIPEDO.5: 6 residues within 4Å:- Chain A: R.41, Q.57, F.58, R.59, L.102
- Ligands: EDO.9
Ligand excluded by PLIPEDO.6: 6 residues within 4Å:- Chain A: D.32, L.35, N.36, R.39
- Ligands: EDO.3, K4O.13
Ligand excluded by PLIPEDO.7: 4 residues within 4Å:- Chain A: M.118, M.121, A.122
- Ligands: K4O.12
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain A: S.54, P.91, E.92, I.93, N.94, P.95
Ligand excluded by PLIPEDO.9: 4 residues within 4Å:- Chain A: R.41, D.44, R.59
- Ligands: EDO.5
Ligand excluded by PLIPEDO.10: 2 residues within 4Å:- Chain A: R.43, D.44
Ligand excluded by PLIPEDO.14: 2 residues within 4Å:- Chain B: Y.16, Q.18
Ligand excluded by PLIPEDO.15: 8 residues within 4Å:- Chain A: A.67, C.68
- Chain B: H.29, D.32, V.33, N.36
- Ligands: K4O.1, EDO.18
Ligand excluded by PLIPEDO.16: 2 residues within 4Å:- Chain B: D.21, S.22
Ligand excluded by PLIPEDO.17: 6 residues within 4Å:- Chain B: R.41, Q.57, F.58, R.59, L.102
- Ligands: EDO.21
Ligand excluded by PLIPEDO.18: 6 residues within 4Å:- Chain B: D.32, L.35, N.36, R.39
- Ligands: K4O.1, EDO.15
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain B: M.118, M.121, A.122
- Ligands: K4O.24
Ligand excluded by PLIPEDO.20: 6 residues within 4Å:- Chain B: S.54, P.91, E.92, I.93, N.94, P.95
Ligand excluded by PLIPEDO.21: 4 residues within 4Å:- Chain B: R.41, D.44, R.59
- Ligands: EDO.17
Ligand excluded by PLIPEDO.22: 2 residues within 4Å:- Chain B: R.43, D.44
Ligand excluded by PLIP- 2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pierrat, O.A. et al., Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assays. Sci Rep (2022)
- Release Date
- 2022-11-16
- Peptides
- B-cell lymphoma 6 protein: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x K4O: ~{N}-[(2-fluorophenyl)methyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine(Non-covalent)
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pierrat, O.A. et al., Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assays. Sci Rep (2022)
- Release Date
- 2022-11-16
- Peptides
- B-cell lymphoma 6 protein: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A